Bio-Rad Laboratories BIO Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories's operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories's operating lease right-of-use assets in other assets?
- Bio-Rad Laboratories (BIO) reported operating lease right-of-use assets in other assets of $161.9M in Q1 2026.
- How has Bio-Rad Laboratories's operating lease right-of-use assets in other assets changed year-over-year?
- Bio-Rad Laboratories's operating lease right-of-use assets in other assets increased by 5.7% year-over-year, from $153.2M to $161.9M.
- What is the long-term trend for Bio-Rad Laboratories's operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Bio-Rad Laboratories's operating lease right-of-use assets in other assets has grown at a -3.4% compound annual growth rate (CAGR), from $202.14M to $170M.